Geode Capital Management’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $69.5K | Buy |
|
|||||
|
2024
Q2 | $38.6K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $8.61K | Buy |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Hold |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|